Pradaxa Injury Lawsuits
The FDA has announced that users of Pradaxa did not find an increased risk of bleeding when compared to the use of the associated drug, warfarin in its most recent evaluation of the drug Pradaxa.
This assessment is correct, however, the FDA failed to state that the drug warfarin includes a reversal agent which would be indispensable if a bleeding emergency were to occur.
Pradaxa, conversely, does not include an antidote which would be essential for anti-clotting and the stoppage of severe and perhaps fatal bleeds.
Currently, over 100 lawsuits have been filed in regard to the adverse effects after use of the drug Pradaxa. If you or a loved one has suffered a serious bleed following the use of Pradaxa, The Edwards Law Firm encourages for you to contact us as soon as possible for a Free Case Review to discuss your legal possibilities.
Pradaxa is an oral medication that is used to prevent strokes and blood clots in patients that suffer from non-valvular atrial fibrillation. Atrial fibrillation is a health condition that causes the heart to beat irregularly, thus increasing an individuals chance of getting blood clots.
Pradaxa belongs to a class of medications called direct thrombin inhibitors, which work by blocking a clotting protein in your blood.
Since Pradaxa was approved by the Food and Drug Administration (FDA) in 2010, patients have reported suffering from severe bleeding injuries that result in hospitalization and sometimes death.
Pradaxa Bleeding Injuries and Deaths
There have been numerous reports of patients suffering from internal bleeding after taking Pradaxa. Boehringer Ingelheim, the German Pharmaceutical company that makes Pradaxa, has reported 260 deaths linked to the drug. Boehringer Ingelheim claims that Pradaxa, also known by its chemical name dabigatran, is as safe as other blood thinning medications. In December 2011, the FDA announced that they were reviewing reports of bleeding injuries associated with Pradaxa.
Other countries have also expressed concerns about Pradaxa injuries. Regulators in Japan told Boehringer Ingelheim to issue a strong warning to physicians about potentially fatal bleeding due to Pradaxa use.
In 2011, European regulators warned the public to have their kidneys checked before using Pradaxa. Individuals with weakened kidneys are at higher risk for internal bleeding.
Signs of Pradaxa Bleeding Injuries
Like other anti-coagulant medications, Pradaxa use comes with the risk of internal bleeding. If you are taking Pradaxa and experience any of the following symptoms, contact your doctor immediately:
- Pink or brown urine
- Unusual bruising or bleeding
- Red or black, tarry stools
- Coughing up blood
- Frequent nosebleeds
- Joint pain or swelling
- Heavy menstrual bleeding
- Swelling of the arms, hands, feet, ankles or legs
- Vomiting blood or a material that looks like coffee grounds
- Bleeding from the gums
Physicians are worried about Pradaxa bleeding events; unlike other blood thinners there is no antidote to stop the bleeding.
Pradaxa patients are also at an increased risk for heart attacks. Research has shown that atrial fibrillation patients that use Pradaxa have a 38 percent higher chance of having heart attacks than patients who take other anti-coagulants.
Pradaxa Lawsuits - Free Case Review
If you or a loved one has sustained injuries after using Pradaxa, you may be entitled to compensation for medical expenses, lost wages and pain and suffering.
Contact the Pradaxa attorneys at The Edwards Law Firm to discuss your legal options.